SpringWorks Therapeutics, Inc.

Historical 13F Holders

Symbol
SWTX
CUSIP
85205L107
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 85205L107 since 12/18/2024, largest first.

Filer % of Class Filed
Vanguard Group Inc 13G/A 9.6% 1/31/2025
Event 12/31/2024
Hudson Bay Capital Management LP 13G
5.2% 8/8/2025
Event 6/30/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Deep Track Capital, LP 13G/A
4.7% 2/14/2025
Event 12/31/2024
FMR LLC 13G/A
1.7% 5/7/2025
Event 4/30/2025
Goldman Sachs Group Inc 13G/A
0% 11/12/2025
Event 9/30/2025
Glazer Capital, LLC 13G
0% 7/7/2025
Event 6/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q2 1 1.00 $47
2026 Q1 1 1.00 $47
2025 Q4 2 40.0 k $2.18M
2025 Q3 4 45.3 k $2.39M
2025 Q2 231 77.6 M $3.65B
2025 Q1 314 74.6 M $3.29B
2024 Q4 222 80.9 M $2.92B
2024 Q3 232 80.8 M $2.59B
2024 Q2 211 77.2 M $2.91B
2024 Q1 221 78.3 M $3.85B
2023 Q4 184 75.4 M $2.75B
2023 Q3 150 68.5 M $1.58B
2023 Q2 146 69.6 M $1.82B
2023 Q1 153 66.3 M $1.70B
2022 Q4 144 66.6 M $1.73B
2022 Q3 154 63.3 M $1.80B
2022 Q2 146 55.3 M $1.36B
2022 Q1 143 49.5 M $2.79B
2021 Q4 147 45.5 M $2.82B
2021 Q3 145 45.1 M $2.86B
2021 Q2 136 44.7 M $3.69B
2021 Q1 139 43.9 M $3.23B
2020 Q4 126 43.4 M $3.15B
2020 Q3 94 37.5 M $1.79B
2020 Q2 79 34.8 M $1.46B
2020 Q1 70 33.0 M $895M
2019 Q4 58 32.0 M $1.23B
2019 Q3 45 31.3 M $681M
2019 Q2 1 53.9 k $4.45M
2019 Q1 1 53.9 k $4.45M